ITGAM and B-cell chronic lymphocytic leukemia: Systemic CLL administration, which allows spread of VACV, depleted bulk DC (Fig 4E) and CD11b+ DC populations (Fig 4F) to a similar extent to the minor depletion with DT, which does not allow spread.